Nature Biotechnology
A monthly journal covering the science and business of biotechnology, with new concepts in technology/methodology of relevance to the biological, biomedical, agricultural and environmental sciences.
Preliminary Phase 2a Readout for a Novel Drug Discovered and Designed Using Generative AI Sets a Major Milestone in AI-Powered Drug Discovery
Insilico Medicine’s AI-Designed Small Molecule Inhibitor for the Treatment of Idiopathic Pulmonary Fibrosis Yields Positive, Promising Phase 2 Trial Data
Precisely programming gene expression in plants
We have developed CRISPRi-based circuits for programming gene expression in plants. These circuits are modular, compact, orthogonal, reversible and programmable and function in various plant species.
Development of supramolecular anticoagulants with on-demand reversibility
Have you ever wanted to target a specific protein but the therapeutic window seemed too risky?
Uniting academics and industry to address unmet medical needs
SPARK at Stanford offers a unique model to advance and de-risk therapeutic research in academia
UBS-seq: An ultrafast bisulfite sequencing method more accurately detecting 5-methylcytosine in DNA and RNA
Current bisulfite sequencing (BS-seq) suffers from notable limitations such as long reaction time, severe DNA damage, overestimation of modification level etc. UBS-seq overcomes these limitations and detects 5-methylcytosine in DNA and RNA accurately starting from low input biological samples.
Virus-inclusive profiling of the human gut microbiome
The human gut contains not only bacteria, but also viruses. Our new tool Phanta allows researchers to quantify these populations simultaneously, offering insights into their complex interactions.
